Trevor Hawkins will join MDS as chief science and technology officer, a newly created position at the company, on May 2. Hawkins will report to John Rogers, president and CEO of MDS. Hawkins most recently served as president of the molecular diagnostics business unit at GE Healthcare. Previously, he was senior vice president of development and new business initiatives at Amersham Biosciences and director of the Human Genome Project at the Department of Energy's Joint Genome Institute.
Lorah Perlee has been named director of scientific applications at Protedyne, the company said this week. Prior to joining the company, Perlee held senior administrative and investigative positions at Molecular Staging, DiagXotics, and Lifecodes.